How many studies have been conducted on Diazepam Binding Inhibitor?

BiohacksAI has indexed 300 PubMed studies on Diazepam Binding Inhibitor. 19% of studies involve human subjects.

What are the main research areas for Diazepam Binding Inhibitor?

The primary research domains for Diazepam Binding Inhibitor are 🧘 Stress & Anxiety, 🔬 Oncology, ⚡ Energy & Fatigue. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Diazepam Binding Inhibitor

An 86-amino acid polypeptide, found in central and peripheral tissues, that displaces diazepam from the benzodiazepine recognition site on the gamma-aminobutyric acid receptor (RECEPTORS, GABA). It also binds medium- and long-chain acyl-CoA esters and serves as an acyl-CoA transporter. This peptide regulates lipid metabolism.

300+ PubMed studies analyzed · Evidence Score: 43.5

Research Domains

Diazepam Binding Inhibitor has been studied across 23 research domains including 🧘 Stress & Anxiety, 🔬 Oncology, ⚡ Energy & Fatigue, 🔥 Metabolic, 🧬 Hormones. The primary research focus is 🧘 Stress & Anxiety with 40% of studies addressing this area.

Loading evidence profile...

This evidence profile for Diazepam Binding Inhibitor is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.